Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Study Highlights Ethnic Diversity of Lupus-Linked Genes

By LabMedica International staff writers
Posted on 03 Aug 2017
A large genotyping study has identified multiple regions of the genome linked to the autoimmune disease systemic lupus erythematosus (SLE) in individuals of European, African, and Hispanic Amerindian ancestry.

SLE is an autoimmune disease with marked gender and ethnic disparities. More...
For example SLE strikes women nine times more frequently than men and its onset is most common during the childbearing years. Furthermore, African-American and Hispanic women are two to three times more likely to develop lupus and tend to have more severe cases than Caucasian women.

A recent study conducted by investigators at Wake Forest Baptist Medical Center (Winston-Salem, NC, USA) and colleagues in Oklahoma, the United Kingdom, and at the biotechnology company Genentech Inc. (San Francisco, CA, USA) analyzed genetic data from 27,574 individuals of European, African American, and Hispanic ancestry using Immunochip genotyping technology that had been designed specifically for autoimmune diseases.

The investigators reported that they had identified 58 regions of the genome linked to SLE in Caucasians, nine in African Americans, and 16 in Hispanics. These regions appeared to be independent of association with HLA (Human Leukocyte Antigen), and nearly 50% of these regions had multiple genetic variants that predisposed to SLE.

"This study is the largest multi-ethnic lupus genetics study to date and allowed us to identify many new genetic markers, some of which are specific to individual ethnic groups and others that are shared across ethnicities," said first author Dr. Carl Langefeld, professor of biostatistical sciences at Wake Forest Baptist Medical Center. "With this information, we can begin to better understand the differences in the rates and severity of disease across ethnic groups. In addition, we observed that many of the genetic markers associated with lupus are shared across numerous autoimmune diseases, and those that are not shared may allow us to understand why a person develops lupus instead of another autoimmune disease. These results will help us identify the biological pathways that pharmaceutical companies may target, and ultimately, develop personalized medicine for the treatment of lupus."

The study was published in the July 17, 2017, online edition of the journal Nature Communications.

Related Links:
Wake Forest Baptist Medical Center
Genentech



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.